Ginsenoside Re Inhibits NLRP3 Inflammasome Activation in Depressive Mice by Promoting PINK1-Mediated Mitophagy

被引:0
|
作者
Liu, Shan [1 ]
Zhang, Yue [2 ]
Zhou, Hao [2 ]
Ma, Yating [2 ]
Huang, Fangzhou [2 ]
Lei, Tianyuan [2 ]
Wang, Qingbin [2 ]
Yu, Shangmin [2 ]
机构
[1] Bengbu Med Univ, Sch Basic Med Sci, Dept Physiol, Bengbu 233000, Anhui, Peoples R China
[2] Bengbu Med Univ, Sch Pharm, Dept Pharmaceut, Bengbu 233000, Anhui, Peoples R China
关键词
ginsenoside Re; depression; PINK1; mitophagy; NLRP3; inflammasome; BEHAVIORS;
D O I
10.1021/acs.jafc.4c09773
中图分类号
S [农业科学];
学科分类号
09 ;
摘要
Ginsenoside Re (Re) was proved effective in improving depressive-like behaviors. However, the potential antidepressant mechanism of Re remains unrevealed. In this study, we investigated whether PINK1-mediated mitophagy and NLRP3 inflammasomes were linked to the antidepressant mechanism of Re in chronic unpredictable mild stress (CUMS) mice and lipopolysaccharide (LPS)-stimulated astrocytes. RNA sequencing and bioinformatics analyses were performed to discover the targets and pathways associated with Re. PTEN-induced putative kinase 1 (PINK1) knockdown was conducted to clarify the role of PINK1-mediated mitophagy in the antidepressant mechanism of Re. The outcomes showed that Re ameliorated depressive-like behaviors, activated PINK1-mediated mitophagy, and inhibited NLRP3 inflammasome activation. PINK1 knockdown attenuated the antidepressant effect of Re. The promotion of mitophagy and the decline of NLRP3 inflammasome activation caused by Re were reversed by PINK1 knockdown. In conclusion, Re inhibited NLRP3 inflammasome activation by promoting PINK1-mediated mitophagy to exert its antidepressant effect.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Anti-atherosclerosis effect of nobiletin via PINK1/Parkin-mediated mitophagy and NLRP3 inflammasome signaling pathway
    Deng, Yudi
    Tu, Yali
    Yang, Xushan
    Liao, Xiaoshan
    Xia, Zijun
    Liao, Wenzhen
    JOURNAL OF FUNCTIONAL FOODS, 2023, 100
  • [22] Dimethyl sulfoxide inhibits NLRP3 inflammasome activation
    Ahn, Huijeong
    Kim, Jeeyoung
    Jeung, Eui-Bae
    Lee, Geun-Shik
    IMMUNOBIOLOGY, 2014, 219 (04) : 315 - 322
  • [23] Helicobacter pylori CagA mediated mitophagy to attenuate the NLRP3 inflammasome activation and enhance the survival of infected cells
    Chen, Dingyu
    Wu, Lixia
    Liu, Xi
    Wang, Qinrong
    Gui, Shuqin
    Bao, Liya
    Wang, Zhengrong
    He, Xiaofeng
    Zhao, Yan
    Zhou, Jianjiang
    Xie, Yuan
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Posttreatment of Maresin1 Inhibits NLRP3 inflammasome activation via promotion of NLRP3 ubiquitination
    Zheng, Sisi
    Ma, Minqi
    Li, Zhongwang
    Hao, Yu
    Li, Hui
    Fu, Panhan
    Jin, Shengwei
    FASEB JOURNAL, 2020, 34 (09) : 11944 - 11956
  • [25] NLRP3 Inflammasome Activation and Altered Mitophagy Are Key Pathways in Inclusion Body Myositis
    Naddaf, Elie
    Nguyen, Thi Kim Oanh
    Watzlawik, Jens O.
    Gao, Huanyao
    Hou, Xu
    Fiesel, Fabienne C.
    Mandrekar, Jay
    Kokesh, Eileen
    Harmsen, William S.
    Lanza, Ian R.
    Springer, Wolfdieter
    Trushina, Eugenia
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2025, 16 (01)
  • [26] NLRP3 inflammasome inhibits mitophagy during the progression of temporal lobe epilepsy
    Mengqian Wu
    Cong Yu
    Fuli Wen
    Yunfei Li
    Xu Zhang
    Yinzhou Wang
    Xiaoqian Chen
    Xingyong Chen
    Scientific Reports, 15 (1)
  • [27] LMP7 inhibits the activation of NLRP3 inflammasome through interaction with NLRP3
    Jin, Jing
    Wang, Wenbiao
    Li, Aixin
    Wu, Jianguo
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 531 (02) : 152 - 159
  • [28] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Hao-yu Wang
    Xi Lin
    Guan-gen Huang
    Rong Zhou
    Shu-yue Lei
    Jing Ren
    Kai-rong Zhang
    Chun-lan Feng
    Yan-wei Wu
    Wei Tang
    Acta Pharmacologica Sinica, 2023, 44 : 1687 - 1700
  • [29] Atranorin inhibits NLRP3 inflammasome activation by targeting ASC and protects NLRP3 inflammasome-driven diseases
    Wang, Hao-yu
    Lin, Xi
    Huang, Guan-gen
    Zhou, Rong
    Lei, Shu-yue
    Ren, Jing
    Zhang, Kai-rong
    Feng, Chun-lan
    Wu, Yan-wei
    Tang, Wei
    ACTA PHARMACOLOGICA SINICA, 2023, 44 (08) : 1687 - 1700
  • [30] Divanillyl sulfone suppresses NLRP3 inflammasome activation via inducing mitophagy to ameliorate chronic neuropathic pain in mice
    Shao, Shuai
    Xu, Cheng-Bo
    Chen, Cheng-Juan
    Shi, Gao-Na
    Guo, Qing-Lan
    Zhou, Yu
    Wei, Ya-Zi
    Wu, Lei
    Shi, Jian-Gong
    Zhang, Tian-Tai
    JOURNAL OF NEUROINFLAMMATION, 2021, 18 (01)